• Cost Curve
  • Posts
  • You Don't Need to Open This Newsletter

You Don't Need to Open This Newsletter

A rare break in the action in DrugPricingLand means this is a good morning for reflection and deep work

One of the great freedoms of the newsletter format is that they can be as long or as short as they need to be. So while I’m going to be verbose some days -- as you may have noticed last week -- there are other days where I’m going appreciate the calm rather than creating artificial waves. 

Today is one of those days. 

There are a couple of smaller items worthy of note -- as well as some milestones I’m waiting on -- but I’ll get to those as they emerge. There aren’t many mornings where we’re not all drinking from the firehose, so here’s to a few extra moments of reflection. 

On the flip side, if I’ve missed something big, please fill my inbox!